Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
RECRUITING
NCT06812117
A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)
720
Enrollment(s)
30
Study location(s)
OBSERVATIONAL (None)
Diabetic Peripheral Neuropathic Pain
RECRUITING
NCT06809764
Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)
150
Enrollment(s)
23
Study location(s)
OBSERVATIONAL (None)
Non-small Cell Lung Cancer
NOT_YET_RECRUITING
NCT06797622
Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer
50
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
Metastatic Breast Cancer
NOT_YET_RECRUITING
NCT06785727
StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial
612
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Ischemic Stroke
Transient Ischemic Attack
RECRUITING
NCT06772246
A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate
70
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Healthy Subjects
NOT_YET_RECRUITING
NCT06769490
Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia
44
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Acute Myeloid Leukemia
RECRUITING
NCT06764875
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
840
Enrollment(s)
205
Study location(s)
INTERVENTIONAL (PHASE3)
HER2-positive Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
COMPLETED
NCT06740825
Study to Assess the Effect of a CYP3A Weak Inducer Rufinamide on Quizartinib Pharmacokinetics in Healthy Subjects
32
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Healthy Subjects
6
7
8
9
10